Stock Track | UltraGreen.ai Soars 3.50% Intraday on Analyst View It's Shielded from Pharma Tariffs

Stock Track
04/07

ULTRAGREEN AI USD (ULG.SI) saw its stock price soar by 3.50% during intraday trading on Tuesday.

The surge follows analysis from DBS Group Research suggesting the company is unlikely to be negatively impacted by the Trump administration's decision to impose a 100% tariff on patented pharmaceutical products. The firm's water-soluble, FDA-approved dye used for fluorescence imaging is classified as a generic drug and falls under the current tariff exemption.

Analysts added that demand for the product is expected to remain relatively price-inelastic, and the company should be able to pass on any potential future tariff-related costs to customers. An additional mitigating factor is that UltraGreen.ai's kits for the Americas are packaged in Michigan. DBS maintains its buy rating and a US$2.00 target price for the stock.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10